
浏览全部资源
扫码关注微信
1.成都大学 食品与生物工程学院,成都 610106
2.四川省中医药科学院 国家中医药管理局中药质量生物评价重点研究室,成都 610041
3.成都中医药大学 药学院,西南特色中药资源省部共建国家重点实验室,成都 611137
4.四川光大制药有限公司,四川 彭州 611930
5.四川省抗病毒中药产业化工程技术研究中心,四川 彭州 611930
谢俊杰,在读硕士,从事药食两用中药大健康产品研究,E-mail:552344522@qq.com
谭鹏,博士,副研究员,从事中药质量标准和品质评价研究,E-mail:410578772@qq.com
收稿日期:2022-06-06,
网络出版日期:2022-08-16,
纸质出版日期:2023-04-05
移动端阅览
谢俊杰,谭鹏,郑川等.基于荧光检测的流感病毒神经氨酸酶中药抑制剂快速筛选方法的建立与应用[J].中国实验方剂学杂志,2023,29(07):185-192.
XIE Junjie,TAN Peng,ZHENG Chuan,et al.Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(07):185-192.
谢俊杰,谭鹏,郑川等.基于荧光检测的流感病毒神经氨酸酶中药抑制剂快速筛选方法的建立与应用[J].中国实验方剂学杂志,2023,29(07):185-192. DOI: 10.13422/j.cnki.syfjx.20220758.
XIE Junjie,TAN Peng,ZHENG Chuan,et al.Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(07):185-192. DOI: 10.13422/j.cnki.syfjx.20220758.
目的
2
建立一种基于荧光检测的流感病毒神经氨酸酶(NA)中药抑制剂快速筛选方法。
方法
2
方法的构建原理是供试品和一定数量的NA作用后,部分NA的活性会被供试品抑制,加入底物后仍具有活性的NA与荧光底物结合后在特定波长下可以产生荧光,根据测得的荧光强度计算供试品对NA的抑制率,从而评估供试品对NA的体外抑制活性。利用建立的方法对来源于12味中药的49个化学成分进行体外抗NA活性评价。利用NA蛋白受体与供试品对接后的结合能和抑制常数的理论计算值来证明实测结果的准确性。将建立的方法应用于检测不同批次板蓝根颗粒和抗病毒颗粒在体外抑制NA的活性,以评价不同批次样品间的质量一致性。
结果
2
方法学考察结果表明该方法具有较好的准确性和重复性。49个成分的筛选结果显示,其中22个成分在体外对NA的抑制活性强于帕拉米韦[半抑制浓度(IC
50
)131.2 μmol·L
-1
],如夏佛塔苷、异荭草苷、诃子酸、胡薄荷酮、异夏佛塔苷等,其余27个成分在体外对NA的抑制活性弱于帕拉米韦。分子对接结果显示,大部分化合物的结合能和抑制常数理论计算结果和实测结果基本一致。12批板蓝根颗粒对NA的抑制活性检测结果显示,样品A1、A2、B2、C1、C2、E2和F2之间的质量一致性较好。同一厂家生产的9批抗病毒颗粒对NA的抑制活性检测结果显示,样品K1~K9在质量浓度为0.02 g·mL
-1
时对NA的抑制率分别为37.68%、36.18%、31.37%、33.98%、40.36%、33.76%、40.69%、41.08%、40.06%,平均值37.24%。
结论
2
该研究成功建立了一种可用于快速评价中药(来源于中药的化学成分或中成药)是否具有体外抗NA活性的分析方法,可作为现有NA抑制剂筛选方法的有力补充。利用该方法从12味中药中筛选得到22个成分对NA具有较好的体外抑制活性,可为研发抗流感小分子药物提供候选化合物。
Objective
2
To establish a rapid screening method for influenza virus neuraminidase(NA) inhibitors sourced from Chinese medicines based on fluorescence detection.
Method
2
The method was constructed based on the principle that after the reaction of the test sample and a certain amount of NA, the activity of some NA will be inhibited by the test sample, and the NA that is still active after the addition of the substrate can generate fluorescence at a specific wavelength when combined with the fluorescent substrate, and the inhibition rate of the test sample on NA was calculated according to the measured fluorescence intensity, so as to evaluate the
in vitro
inhibitory activity of the test sample on NA. A total of 49 high-purity chemical components from 12 Chinese medicines were used to evaluate the
in vitro
anti-NA activity by the established method. The theoretical calculated values of binding energy and inhibition constant after docking between the NA protein receptor and the test sample were used to prove the accuracy of the experimental results. The established method was applied to detect the
in vitro
NA inhibitory activity of different batches of Banlangen granules and Kangbingdu granules, so as to evaluate the quality consistency among different batches of samples.
Result
2
The methodological examination results showed that the method had good accuracy and repeatability. The screening results of 49 components showed that 22 of them had strong
in vitro
inhibitory activity against NA than peramivir [half inhibitory concentration(IC
50
) was 131.2 μmol·L
-1
], such as schaftoside, isoorientin, chebulinic acid, menthone and isoschaftoside. The inhibitory activity of the remaining 27 components was weaker than that of peramivir. The molecular docking results showed that the theoretical calculation results of binding energies and inhibition constants of most compounds were basically consistent with the experimental results. The test results of the inhibitory activity of 12 batches of Banlangen granules on NA showed that the quality consistency among samples A1, A2, B2, C1, C2, E2 and F2 was good. The analysis results of the inhibitory activity of 9 batches of Kangbingdu granules produced by the same manufacturer on NA showed that the inhibitory rates of samples K1 to K9 were 37.68%, 36.18%, 31.37%, 33.98%, 40.36%, 33.76%, 40.69%, 41.08%, 40.06% when the concentration of 0.02 g·mL
-1
, and the average inhibitory rate was 37.24%.
Conclusion
2
In this paper, we successfully established an analytical method that can be used to rapidly evaluate whether Chinese medicines (derived from chemical components of traditional Chinese medicine or proprietary Chinese medicines) have
in vitro
anti-NA activity, which can be a powerful supplement to the existing screening methods for influenza virus NA inhibitors. And this method was used to screen 22 compounds from 12 Chinese medicines with good
in vitro
inhibitory activity against NA, which can provide candidate compounds for the development of anti-influenza small molecule drugs.
PAULES C , SUBBARAO K . Influenza [J]. Lancet , 2017 , 390 ( 10095 ): 697 - 708 .
昝树杰 , 张俊华 , 吕玲 . 张伯礼教授对2017年冬至2018年春流感治疗策略 [J]. 天津中医药 , 2019 , 36 ( 1 ): 3 - 6 .
KWONG J C , SCHWARTZ K L , CAMPITELLI M A , et al . Acute myocardial infarction after laboratory-confirmed influenza infection [J]. N Engl J Med , 2018 , 378 ( 4 ): 345 - 353 .
GANDHI R T , LYNCH J B , DEL-RIO C . Mild or moderate COVID-19 [J]. N Engl J Med , 2020 , 383 ( 18 ): 1757 - 1766 .
中国中西医结合学会 . 新型冠状病毒肺炎中西医结合防治专家共识 [J]. 中国中西医结合杂志 , 2020 , 40 ( 12 ): 1413 - 1423 .
MARR L C , TANG J W , VAN-MULLEKOM J , et al . Mechanistic insights into the effect of humidity on airborne influenza virus survival,transmission and incidence [J]. J R Soc Interface , 2019 , 16 ( 150 ): 20180298 .
JACKSON M L , CHUNG J R , JACKSON L A , et al . Influenza vaccine effectiveness in the united states during the 2015—2016 season [J]. N Engl J Med , 2017 , 377 ( 6 ): 534 - 543 .
PENG X Y , XIAO Y C , LI L , et al . Curative efficacy and safety of peramivir in the treatment of children suspected with influenza [J]. Eur J Inflamm , 2020 , doi: 10.1177/2058739220946139 http://dx.doi.org/10.1177/2058739220946139 .
李振华 , 张华 , 陈建丽 , 等 . 帕拉米韦与奥司他韦治疗流感病毒性肺炎的效果 [J]. 中华医院感染学杂志 , 2021 , 31 ( 24 ): 3717 - 3721 .
石克华 , 余小萍 . 中医治疗传染性非典型肺炎的优势 [J]. 上海中医药杂志 , 2003 , 37 ( 12 ): 3 - 4 .
孙易娜 , 吕文亮 , 李昊 , 等 . 清肺排毒汤治疗轻型/普通型新型冠状病毒肺炎295例多中心临床研究 [J]. 中医杂志 , 2021 , 62 ( 7 ): 599 - 603 .
刘畅 , 闫艳韬 , 王娟 , 等 . 绵马贯众中间苯三酚类化合物抗流感病毒的活性筛选 [J]. 中草药 , 2018 , 49 ( 2 ): 305 - 312 .
YU G Y , FANG D . Evaluation of neuraminidase inhibitory activity of compounds and extracts from traditional medicines by HPLC-FLD [J]. Int J Anal Chem , 2021 , 2021 : 6694771 .
杨贤英 , 李金花 , 段宝忠 , 等 . 五倍子抑制流感病毒神经氨酸酶活性及活性部位的UPLC-Q-TOF-MS分析 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 16 ): 68 - 72 .
PATEL H , KUKOL A . Integrating molecular modelling methods to advance influenza a virus drug discovery [J]. Drug Discov Today , 2021 , 26 ( 2 ): 503 - 510 .
刘舒 , 邢俊鹏 , 闫峻 , 等 . 中药黄芩中神经氨酸酶抑制剂的超滤质谱筛选研究 [J]. 化学学报 , 2011 , 69 ( 13 ): 1570 - 1574 .
马丽娜 , 章从恩 , 鄢丹 , 等 . 超滤质谱技术筛选板蓝根中抗流感病毒的活性成分 [J]. 中国中药杂志 , 2014 , 39 ( 5 ): 812 - 816 .
LIU J W , ZU M , CHEN K T , et al . Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines [J]. BMC Complement Altern Med , 2018 , 18 ( 1 ): 102 .
ZHANG J J , LIU T , TONG X M , et al . Identification of novel virus inhibitors by influenza a virus specific reporter cell based screening [J]. Antiviral Res , 2012 , 93 ( 1 ): 48 - 54 .
张洪江 , 何立巍 , 唐敏 . 板蓝根中黄酮类化合物抗流感病毒的分子对接研究 [J]. 化工时刊 , 2018 , 32 ( 3 ): 19 - 21 .
倪雯婷 , 马大龙 , 邵骏菁 , 等 . 基于网络药理学和实验验证探索荆防合剂治疗甲型H1N1流感的作用机制 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 12 ): 200 - 209 .
中华中医药学会 . 2021年度中医药十大学术进展 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 14 ): 1 - 12 .
裴科 , 宁燕 , 蔡皓 , 等 . 基于UHPLC-Q-Orbitrap HRMS和整合网络药理学的川芎酒制后增强抗脑缺血损伤作用机制分析 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 12 ): 164 - 173 .
0
浏览量
33
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621